Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial
Clinical Nutrition · 2023
DOI: 10.1016/j.clnu.2023.06.022 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2023. Verfasst von Lourdes Barbosa-Cortés und 19 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación Médica en Nutrición, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Inst…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: N-3 polyunsaturated fatty acids (LCPUFA-ω3), particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) might have beneficial effects on lean mass and fat mass synthesis. OBJECTIVE: To investigate the effect of LCPUFA-ω3 supplementation on body composition changes in children with acute lymphoblastic leukemia (ALL) at remission and three months (3 mo) after supplementation. METHODS: This randomized controlled trial enrolled 72 children (3-13 y) with newly diagnosed ALL (placebo group [500 mg sunflower oil]: 36 patients; LCPUFA-ω3 group [225 mg DHA, 45 mg EPA]: 36 patients). LCPUFA-ω3 was administered at 0.100 g/kg of body weight/day for 3 mo. Both groups were provided with an oral milkshake supplement. MAIN OUTCOMES AND MEASURES: Body composition was measured at diagnosis, remission, and 3 months after supplementation by dual-energy X-ray absorptiometry (DXA). Red blood cell fatty acid analyses were performed with gas chromatography. Student's t test compared the percentage changes in body weight, total body fat percentage (TBFP), and lean body mass (LBM) between the groups. The Mann-Whitney U test was used to compare the groups, and the Friedman range test and Wilcoxon signed rank test were used for intratreatment comparisons. Spearman correlation coefficients were calculated for LBM and erythrocyte LCPUFA-ω3 content. RESULTS: LBM decreased significantly in both groups. This loss was greater in the placebo group than in the LCPUFA-ω3 group at remission (p = 0.044) and at 3 months of supplementation (p = 0.039). There were significant and progressive increases in DHA and EPA concentrations in the LCPUFA-ω3 group (p < 0.001). LBM at remission was directly correlated with increased DHA (r = 0.487, p = 0.034) and EPA (r = 0.499, p = 0.030) erythrocytes in the LCPUFA-ω3 group. CONCLUSION: At ALL diagnosis and during the first three months of treatment, 100 mg/kg of body weight/d DHA and EPA decreased LBM loss and allowed the incorporation of fatty acids into cell membranes (clinicaltriasl.gov #: NCT01051154).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Investigación Médica en Nutrición, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México. Ele…
- Unidad de Investigación Médica en Nutrición, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México.
- Laboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, México; Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
- Servicio de Hematología, Unidad Médica de Alta Especialidad /(UMAE), Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México.
- Departamento de Hematología Pediátrica, Unidad Médica de Alta Especialidad (UMAE), Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Ciudad de México, México.
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Barbosa-Cortés, L., Martínez-Vieyra, X., Mejía-Aranguré, J. M., López-Alarcón, M., Martin-Trejo, J., Delgadillo-Portillo, S., Guzmán-Castro, B., Delgadillo-Portillo, J., Atilano-Miguel, S., Rodríguez-Cruz, M., Maldonado-Hernández, J., Añoveros-Barrera, A., Solís-Labastida, K. A., Espinoza-Hernández, L., Nuñez-Villegas, N. N., Jiménez-Hernández, E., Bautista-Martínez, B. A., Juárez-Moya, A., Hernández-Piñón, Z., & Pérez-Casillas, R. X. (2023). Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.06.022
Vancouver
Barbosa-Cortés L, Martínez-Vieyra X, Mejía-Aranguré JM, López-Alarcón M, Martin-Trejo J, Delgadillo-Portillo S, et al. Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial. Clinical Nutrition. 2023. doi:10.1016/j.clnu.2023.06.022
BibTeX
@article{BarbosaCorts2023,
author = {Barbosa-Cortés, Lourdes and Martínez-Vieyra, Ximena and Mejía-Aranguré, Juan Manuel and López-Alarcón, Mardia and Martin-Trejo, Jorge and Delgadillo-Portillo, Suily and Guzmán-Castro, Brenda and Delgadillo-Portillo, Jazmín and Atilano-Miguel, Salvador and Rodríguez-Cruz, Maricela and Maldonado-Hernández, Jorge and Añoveros-Barrera, Ana and Solís-Labastida, Karina A and Espinoza-Hernández, Laura and Nuñez-Villegas, Nora N and Jiménez-Hernández, Elva and Bautista-Martínez, Benito A and Juárez-Moya, Azalia and Hernández-Piñón, Zayra and Pérez-Casillas, Ruy Xavier},
title = {Pilot study on the effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on body composition in children with acute lymphoblastic leukemia: randomized clinical trial},
journal = {Clinical Nutrition},
year = {2023},
doi = {10.1016/j.clnu.2023.06.022}
}
EUVIMED